Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EM703

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ABSTRACT Macrolide antibiotics are used as anti-inflammatory agents, e.g., for prevention of exacerbations in chronic obstructive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2013
2013
Diesel exhaust particle (DEP) is the major components of PM2.5, and much attention has focused on PM2.5 in relation to adverse… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2008
Review
2008
Macrolide antibiotics administered in sub-antimicrobial doses improve pulmonary function and decrease exacerbation frequency for… Expand
  • figure 1
  • figure 2
  • figure 3
2008
2008
BACKGROUND Excessive accumulation of collagen in the skin and internal organs in systemic sclerosis (SSc) is considered to result… Expand
2008
2008
Long-term, low-dose macrolide therapy has been proven to improve survival in patients with diffuse panbronchiolitis and cystic… Expand
2008
2008
Macrophages (MΦs) are a major source of HIV-1 especially in patients with tuberculosis. There are MΦs that are permissive and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2006
Highly Cited
2006
BackgroundFourteen-membered ring macrolides have been effective in reducing chronic airway inflammation and also preventing lung… Expand
2006
2006
EM703, which is an erythromycin derivative synthesized by our group, has a potent promoting activity of monocyte-to-macrophage… Expand
2005
2005
AbstractWe have been interested in the immunomodulatory effect, to promote differentiation of the human monocytic cell line THP-1… Expand
  • figure 1
  • table 1
Highly Cited
2004
Highly Cited
2004
ABSTRACT Long-term macrolide therapy has been proven to improve survival in patients with diffuse panbronchiolitis. Although its… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5